Newborn screening analytes
| Marker type | Analytes measured |
| Acyl-carnitines, Acylcarnitine ratios, other | C0, C0|C16, C18, C0, C2, C3, C16, C18|Cit C2 C3, C3DC, C3|C0, C3|C16, C3, C2, C3|C4DC C4, C4OH, C4DC C5, C5:1, C5DC, C5OH, C5|C0, C5|C2, C5|C3, C5DC|C16, C5DC|C5OH, C5DC|C8, C5OH|C2, C5OH|C5:1, C5OH|C8 C6, C6DC C8, C8:1, C8|C10, C8|C2 C10, C10:1 C12, C12:1 C14, C14:1, C14:2, C14:1|C12:1, C14:1|C16, C14.1|C4, C14OH C16, C16OH, C16:1OH C16:1OH|C4DC, C16OH|C16 C18, C18:1, C18:2, C18OH, C18:1OH Medium-chain acyl-CoA |
| Amino acids, amino acid ratios, other | Alanine, arginine, citrulline, glycine, leucine, methionine, ornithine, phenylalanine, succinylacetone, tyrosine, valine, citrulline:arginine, leucine:alanine, leucine:phenylalanine, methionine:phenlyalanine, phenylalanine:tyrosine, valine:phenylalanine |
| Cystic fibrosis markers | Immunoreactive trypsinogen (IRT), cystic fibrosis transmembrane conductance regulator gene (CFTR) mutation 1, CFTR mutation 2, intron 8 polythymidine tract (5T/7T/9T) |
| Endocrine markers | Thyroid-stimulating hormone, 17-hydroxyprogesterone (17OHP), androstenedione, cortisol |
| Enzyme markers | Biotinidase (BIOT), galactose-1-phosphate uridyl transferase (GALT) |
| T-cell function | T-cell receptor excision circles (TRECs) |
| Haemoglobin variants, haemoglobinopathies and peak percentages | Haemoglobin (HGB): adult haemoglobins, HbA(A) and variants (S, C, D, E, B-thal) HGB peak percentages: HGB-FAST, HGB-F1, HGB-F, HGB-F+F1, HGBFAST+F1, HGB-Other, HGB-A |
| Purines | Adenosine, deoxyadenosine, guanosine, deoxyguanosine, inosine, deoxyinosine, xanthine, hypoxanthine |